ANDA 76032, held by Able Laboratories. Methylphenidate Hydrochloride.
As of Nov 21, 2026, ANDA 76032 (Methylphenidate Hydrochloride), held by Able Laboratories, was first approved by FDA on May 9, 2001, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 9, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Methylphenidate Hydrochloride20MG · tablet, extended release;oral | Methylphenidate Hydrochloride | Discontinued |
| Nov 18, 2003 | Supplement 3Labeling | Approved | None posted |
| Mar 5, 2003 | Supplement 2Labeling | Approved | None posted |
| Oct 16, 2001 | Supplement 1Manufacturing | Approved | None posted |
| May 9, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters